Innate Pharma to Engage Investors at Global Conferences
Company Announcements

Innate Pharma to Engage Investors at Global Conferences

Innate Pharma SA (FR:IPH) has released an update.

Innate Pharma SA, a biotechnology company focused on cancer immunotherapies, is set to participate in several key investor conferences across New York, London, and Miami from November to December 2024. This participation highlights the company’s ongoing efforts to engage with investors and showcase its innovative therapeutic approaches. Innate Pharma is publicly traded on Euronext Paris and Nasdaq, making these conferences an important opportunity for potential stakeholders.

For further insights into FR:IPH stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskInnate Pharma Appoints New CEO to Drive Growth
TheFlyInnate Pharma appoints Jonathan Dickinson as CEO
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App